1,2,3,4-Tetrahydroisoquinoline

1,2,3,4-Tetrahydroisoquinoline

SCHEMBL4892220

c1ccc(-c2ccc3c(c2)CNCC3)cc1.c1ccc2c(c1)CCNC2

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PNMT P11086 5/20 0.66
CD44 P16070 1/20 0.66
MAOB P27338 1/20 0.66
ASIC3 Q9UHC3 4/20 0.57
ADRA2A P08913 1/20 0.51
ADRA2B P18089 1/20 0.51
ADRA2C P18825 1/20 0.51
PRCP P42785 1/20 0.50
HTR2C P28335 1/20 0.50
CD274 Q9NZQ7 1/20 0.50
CFD P00746 1/20 0.49
F11 P03951 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30593253 0.96 PNMT (0.59) PNMTCD44MAOBASIC3ADRA2A
SCHEMBL4663734 0.96 PNMT (0.59) PNMTCD44MAOBASIC3ADRA2A
SCHEMBL6347388 0.93 ASIC3 (0.65) PNMTCD44MAOBASIC3PRCP
Biphenyl SCHEMBL27799394 0.89 PNMT (0.83) PNMTCD44MAOBASIC3ADRA2A
SCHEMBL29543554 0.85 TYRO3 (0.50) PNMTCD44MAOBASIC3CD274
SCHEMBL8676339 0.85 TYRO3 (0.50) PNMTCD44MAOBASIC3CD274
1,2,3,4-Tetrahydroisoquinoline SCHEMBL19085 0.81 PNMT (1.00) PNMTCD44MAOBASIC3ADRA2A
1,2,3,4-Tetrahydroisoquinoline SCHEMBL29360217 0.81 PNMT (1.00) PNMTCD44MAOBASIC3ADRA2A
1,2,3,4-Tetrahydroisoquinoline SCHEMBL28236302 0.81 PNMT (1.00) PNMTCD44MAOBASIC3ADRA2A
SCHEMBL7216445 0.81 ASIC3 (0.54) PNMTASIC3ADRA2AADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7320989-B2 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-22 US disclosed